发明名称 |
BOROPROLINE COMPOUND COMBINATION THERAPY |
摘要 |
A method id provided for treating subjects with combination therapy includin g compounds of Formula I. It was surprisingly discovered that this combination enhanced the efficacy of both agents, and that administration of Formula I compounds induced cytokine and chemokine production in vivo. The combination s can be used to enhanced ADCC, stimulate immune responses and /or patient and treat certain disorders. The invention also relates to kits and compositions relating to such combinations.
|
申请公布号 |
CA2491474(A1) |
申请公布日期 |
2004.01.15 |
申请号 |
CA20032491474 |
申请日期 |
2003.07.09 |
申请人 |
POINT THERAPEUTICS, INC. |
发明人 |
MILLER, GLENN T.;JESSON, MICHAEL I.;JONES, BARRY;ADAMS, SHARLENE |
分类号 |
A61K31/69;A61K38/05;A61K38/06;A61K38/17;A61K38/21;A61K39/395;A61K45/06;(IPC1-7):A61K39/395;A61K39/00;A61P31/00;A61P35/00;A61K38/04 |
主分类号 |
A61K31/69 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|